Profile data is unavailable for this security.
About the company
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
- Revenue in EUR (TTM)493.25m
- Net income in EUR35.83m
- Incorporated1967
- Employees2.81k
- LocationBoiron SA2 avenue de l ouest LyonnaisRONTALON 69510FranceFRA
- Phone+33 478456100
- Fax+33 478456291
- Websitehttps://www.boiron.fr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deva Holding AS | 219.58m | 66.34m | 440.35m | 2.93k | 6.64 | 2.64 | 6.11 | 2.01 | 11.54 | 11.54 | 38.20 | 28.97 | 0.7464 | 1.49 | 6.52 | 2,686,365.00 | 22.55 | 21.33 | 43.27 | 33.37 | 56.78 | 53.72 | 30.21 | 32.51 | 0.9899 | -- | 0.4776 | 2.77 | 92.15 | 41.11 | 16.25 | 71.18 | 58.49 | -- |
| Valneva SE | 153.71m | -101.43m | 478.28m | 684.00 | -- | 3.72 | -- | 3.11 | -0.7343 | -0.7343 | 1.11 | 0.924 | 0.2843 | 2.54 | 4.69 | 224,726.60 | -18.76 | -15.39 | -31.44 | -25.06 | 34.37 | 35.94 | -65.99 | -34.95 | 1.37 | -3.57 | 0.6195 | -- | -57.46 | 6.34 | 29.21 | -- | 35.18 | -- |
| Guerbet SA | 785.69m | 23.87m | 480.36m | 2.92k | 21.13 | 1.27 | 5.77 | 0.6114 | 1.80 | 1.80 | 62.15 | 29.97 | 0.7997 | 0.5983 | 5.80 | 269,071.90 | 2.26 | 1.40 | 2.96 | 1.86 | 78.01 | 76.02 | 2.82 | 1.82 | 1.21 | 5.62 | 0.5035 | 57.82 | 4.30 | -0.0993 | 158.05 | -12.61 | 5.23 | -10.07 |
| Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS | 234.28m | 13.06m | 501.81m | 622.00 | 38.41 | 3.61 | 24.31 | 2.14 | 1.52 | 1.52 | 27.17 | 16.12 | 1.16 | 6.53 | 7.72 | 13,105,500.00 | 6.45 | 12.39 | 8.91 | 17.53 | 22.07 | 19.06 | 5.55 | 6.95 | 0.9854 | -- | 0.2095 | -- | -23.38 | 47.18 | -28.97 | 147.97 | -- | -- |
| Pharmanutra SpA | 100.20m | 12.83m | 504.38m | 105.00 | 39.04 | 9.21 | 33.51 | 5.03 | 1.33 | 1.33 | 10.41 | 5.66 | 0.9426 | 0.3648 | 4.90 | 954,304.80 | 12.07 | 18.39 | 16.12 | 24.80 | 97.56 | 96.36 | 12.81 | 17.77 | 1.83 | 57.61 | 0.3399 | 52.51 | 21.13 | 16.51 | -14.73 | 8.44 | 75.71 | 11.20 |
| Philogen SpA | 23.13m | -6.16m | 524.91m | 160.00 | -- | 7.98 | -- | 22.69 | -0.1551 | -0.1551 | 0.5747 | 2.25 | 0.1887 | 6.65 | 7.95 | 144,562.50 | -5.03 | -7.32 | -5.56 | -8.36 | 40.04 | 32.04 | -26.64 | -58.66 | 6.84 | -- | 0.1414 | -- | -2.46 | 10.80 | -14.60 | -- | 51.78 | -- |
| Basilea Pharmaceutica AG Allschwil | 161.77m | 10.73m | 536.47m | 147.00 | 45.52 | -- | 43.38 | 3.32 | 0.8765 | 0.8765 | 13.15 | -0.8335 | 0.7999 | 1.06 | 5.16 | 1,072,340.00 | 5.30 | -1.86 | 7.69 | -2.99 | 83.00 | 83.45 | 6.63 | -2.99 | 2.64 | 2.02 | 1.10 | -- | 6.68 | 3.53 | -13.96 | -- | 11.17 | -- |
| Calliditas Therapeutics AB | 103.64m | -40.03m | 545.41m | 195.00 | -- | 17.09 | -- | 5.26 | -8.69 | -8.69 | 22.49 | 6.24 | 0.6332 | 5.02 | 9.30 | 6,189,175.00 | -24.46 | -26.46 | -30.27 | -30.27 | 94.99 | -- | -38.63 | -76.59 | 3.08 | -4.44 | 0.7427 | -- | 50.32 | -- | -13.08 | -- | -- | -- |
| Pharma Mar SA | 162.14m | 2.03m | 571.57m | 509.00 | 286.87 | 2.85 | 71.45 | 3.53 | 0.1086 | 0.1086 | 9.10 | 10.92 | 0.4583 | 0.2431 | 6.31 | 318,546.20 | 0.5726 | 18.52 | 0.7699 | 25.89 | 94.30 | 93.76 | 1.25 | 28.87 | 2.14 | -- | 0.17 | -- | -19.45 | 7.77 | -97.70 | -- | 46.37 | -- |
| Boiron SA | 493.25m | 35.83m | 592.16m | 2.81k | 16.36 | 1.49 | 10.70 | 1.20 | 2.06 | 2.06 | 28.41 | 22.67 | 0.715 | 1.40 | 5.26 | 175,533.10 | 4.92 | 4.59 | 6.16 | 5.76 | 72.60 | 74.02 | 6.88 | 6.80 | 1.50 | -- | 0.0338 | 53.86 | -7.67 | -3.98 | -19.80 | -9.01 | -17.68 | -1.42 |
| Pharming Group N.V. | 228.03m | -9.80m | 601.11m | 415.00 | -- | 2.96 | 120.27 | 2.64 | -0.0161 | -0.0161 | 0.3471 | 0.303 | 0.5521 | 0.5089 | 6.65 | 549,472.40 | -2.37 | 5.26 | -2.81 | 6.63 | 89.72 | 89.41 | -4.30 | 9.26 | 3.33 | -4.00 | 0.4395 | -- | 19.30 | 9.01 | -177.14 | -- | -13.04 | -- |
| Gubra A/S | 27.49m | -5.97m | 657.80m | 219.00 | -- | 10.19 | -- | 23.93 | -2.91 | -2.91 | 13.51 | 29.44 | -- | -- | -- | 936,095.90 | -- | -- | -- | -- | 56.06 | -- | -21.72 | -- | -- | -- | 0.1296 | -- | 2.82 | -- | -1,133.04 | -- | -- | -- |
| Surgical Science Sweden AB | 75.81m | 20.09m | 675.24m | 260.00 | 33.58 | 1.81 | 27.15 | 8.91 | 4.59 | 4.59 | 17.32 | 85.16 | 0.1888 | 1.87 | 6.15 | 3,395,585.00 | 5.00 | 4.49 | 5.31 | 4.78 | 69.42 | 70.06 | 26.50 | 23.75 | 3.56 | -- | 0.00 | 0.00 | 10.01 | 68.14 | 24.47 | -- | 38.57 | -- |
| Puretech Health PLC | 3.10m | -61.07m | 688.63m | 90.00 | -- | 1.61 | -- | 222.47 | -0.188 | -0.188 | 0.0095 | 1.36 | 0.0048 | -- | 0.4676 | 29,496.03 | -9.54 | 4.92 | -10.67 | 5.94 | -- | -- | -2,000.84 | 352.67 | -- | -- | 0.0524 | 0.00 | -78.68 | -30.64 | -30.47 | -- | -44.10 | -- |
Data as of May 03 2024. Currency figures normalised to Boiron SA's reporting currency: Euro EUR
4.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Financi�re de l'�chiquier SAas of 28 Dec 2023 | 238.57k | 1.36% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 136.70k | 0.78% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 83.74k | 0.48% |
| SMA Gestion SAas of 30 Jun 2021 | 76.17k | 0.43% |
| Sycomore Asset Management SAas of 31 Jan 2024 | 69.77k | 0.40% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 47.88k | 0.27% |
| HC Capital Advisors GmbHas of 30 Jun 2023 | 38.51k | 0.22% |
| Gay-Lussac Gestion SAas of 31 Dec 2022 | 32.50k | 0.19% |
| Amplegest SASas of 31 Aug 2023 | 24.91k | 0.14% |
| Chaussier Gestion SAas of 28 Mar 2024 | 17.00k | 0.10% |
More ▼
Data from 30 Jun 2021 - 31 Mar 2024Source: FactSet Research Systems Inc.
